These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33278493)
21. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation. Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795 [TBL] [Abstract][Full Text] [Related]
22. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses. Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001 [TBL] [Abstract][Full Text] [Related]
23. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468 [TBL] [Abstract][Full Text] [Related]
24. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Pietrzak K; Isreb A; Alhnan MA Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660 [TBL] [Abstract][Full Text] [Related]
25. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment. Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925 [TBL] [Abstract][Full Text] [Related]
26. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916 [TBL] [Abstract][Full Text] [Related]
27. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form. Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916 [TBL] [Abstract][Full Text] [Related]
28. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction. Nukala PK; Palekar S; Patki M; Patel K AAPS PharmSciTech; 2019 Jan; 20(2):80. PubMed ID: 30645704 [TBL] [Abstract][Full Text] [Related]
29. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Arafat B; Wojsz M; Isreb A; Forbes RT; Isreb M; Ahmed W; Arafat T; Alhnan MA Eur J Pharm Sci; 2018 Jun; 118():191-199. PubMed ID: 29559404 [TBL] [Abstract][Full Text] [Related]
30. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898 [TBL] [Abstract][Full Text] [Related]
31. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316 [TBL] [Abstract][Full Text] [Related]
33. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production. Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253 [TBL] [Abstract][Full Text] [Related]
34. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134 [TBL] [Abstract][Full Text] [Related]
35. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. Genina N; Boetker JP; Colombo S; Harmankaya N; Rantanen J; Bohr A J Control Release; 2017 Dec; 268():40-48. PubMed ID: 28993169 [TBL] [Abstract][Full Text] [Related]
36. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147 [TBL] [Abstract][Full Text] [Related]
37. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness. Obeid S; Madžarević M; Ibrić S Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830 [TBL] [Abstract][Full Text] [Related]
38. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone. Chai X; Chai H; Wang X; Yang J; Li J; Zhao Y; Cai W; Tao T; Xiang X Sci Rep; 2017 Jun; 7(1):2829. PubMed ID: 28588251 [TBL] [Abstract][Full Text] [Related]
39. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246 [TBL] [Abstract][Full Text] [Related]
40. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]